Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028
Surgical
hemostat is a surgical tool used in many surgical procedures to control
bleeding. Surgical hemostats covered in this report include thrombin-based,
combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and
collagen-based. Internal tissue sealants are typically used in surgeries to
bind or hold internal tissues such as blood vessels, internal organs, bone
cartilage, dura matter and others.
The global surgical hemostats,
internal tissue sealants and adhesion barriers market is estimated to account
for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$
7,346.7 Mn by the end of 2027
Global
Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers
Increasing number of surgical
procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and
adhesion barriers market over the forecast period. For instance, according to
‘Surgical operations and procedures statistics’ of Eurostat in November 2019,
at least 1.4 million caesarean sections performed in the EU in 2017.
Moreover, high incidence of early
postoperative small bowel obstruction is also expected to aid in growth of the
market. For instance, according to the study, “Incidence and risk factors of
early postoperative small bowel obstruction in patients undergoing hysterectomy
for benign indications”, published in the American Journal of Obstetrics and
Gynecology, in March 2019, the incidence rate of early small bowel obstructions
was 5.9 per 1000 hysterectomies and 43.7% of the study population developed
small bowel obstruction during the initial hospital stay and 23.1% underwent
reoperation.
High number of cardiovascular
procedures is expected to propel growth of the global surgical
hemostats, internal tissue sealants and adhesion barriers market over the
forecast period. For instance, according to American Heart Association 2019
Heart Disease and Stroke Statistics, 1,016,000 cardiac catheterizations and
3,244 heart transplants were performed in the U.S. in 2014 and 2017,
respectively.
Statistics:
Hemostat held dominant position in
the global surgical hemostats, internal tissue sealants and adhesion barriers market
in 2019, accounting for 41.1% share
in terms of value, followed by Internal Tissue Sealants, and adhesion barriers
respectively
Comments
Post a Comment